Clinical Trial

Endoscopic Assisted Latissimus Dorsi Musculocutaneous Flap for Breast Reconstruction

Completed
View on ClinicalTrials.gov →
Summary
This prospective single-arm case series evaluates the feasibility, safety, and clinical outcomes of endoscopic-assisted latissimus dorsi musculocutaneous flap harvest for breast reconstruction. The study includes women with post-oncologic or post-burn breast deformities requiring autologous tissue reconstruction with a skin paddle measuring 6 cm or less in its greatest dimension. The primary objective is to assess the feasibility of minimally invasive flap harvest while preserving reconstructive effectiveness. Secondary outcomes include flap viability, operative time, postoperative pain, drain duration, donor-site morbidity, scar quality, complications, and patient satisfaction. Patients are followed for one year after surgery, with clinical assessment and patient-reported outcome measures used to evaluate reconstructive and aesthetic results.
Trial Details
NCT Number NCT07691294
Lead Sponsor Kasr El Aini Hospital
Conditions Acquired Breast Deformity, Breast Cancer, Post Burn Breast Deformities
Enrollment 15 participants
Start Date 2023-01-25
Primary Completion 2024-01-15 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-08